- Trials with a EudraCT protocol (691)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (2)
691 result(s) found for: Identification.
Displaying page 3 of 35.
EudraCT Number: 2007-000504-32 | Sponsor Protocol Number: L00013 SP 401 | Start Date*: 2007-04-10 |
Sponsor Name:Pierre Fabre Médicament | ||
Full Title: Analyse du profil sensoriel du sirop antihistaminique Primalan®, versus un sirop antihistaminique de reference : Aerius® | ||
Medical condition: Réalisation du profil sensoriel comparatif de 2 sirops antihistaminiques | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: FR (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2015-004869-88 | Sponsor Protocol Number: HS2116100 | Start Date*: 2016-12-21 |
Sponsor Name:GlaxoSmithKline K.K. (GSK) | ||
Full Title: A multicenter, open-label study to evaluate preventive efficacy for herpes simplex virus infection and safety of 256U87 (valaciclovir hydrochloride) in adult and pediatric hematopoietic stem cell t... | ||
Medical condition: Herpes simplex virus (HSV) infection before and after hematopoietic stem cell transplantation. | ||
Disease: | ||
Population Age: Infants and toddlers, Children, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |
Trial protocol: Outside EU/EEA | ||
Trial results: View results |
EudraCT Number: 2011-002527-18 | Sponsor Protocol Number: FluoGlio2011 | Start Date*: 2011-07-06 |
Sponsor Name:ISTITUTO NEUROLOGICO "CARLO BESTA" | ||
Full Title: Phase II, open label, monocentric, uncontrolled, non randomized clinical trial on Sodium Fluorescein for Surgery of High Grade Gliomas. | ||
Medical condition: Intracranial high grade gliomas | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: IT (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2020-004115-27 | Sponsor Protocol Number: IIBSP-OXI-2020-102 | Start Date*: 2021-05-10 |
Sponsor Name:Institut de Recerca Hospital de la Santa Creu i Sant Pau - IIB Sant Pau | ||
Full Title: Identification and clinical relevance of oxytocin deficient status: randomized, crossover, placebo-controlled pathophysiological pilot study: GLP1 study | ||
Medical condition: Hypopituitarism | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2007-005364-27 | Sponsor Protocol Number: 12/2007/U/Sper | Start Date*: 2007-09-25 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI | |||||||||||||
Full Title: Ultrasonographic characterization of small nodules in cirrhotic patients using contrast media through splancnic infusion | |||||||||||||
Medical condition: hepatic cirrhosis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-004231-12 | Sponsor Protocol Number: NL20151001 | Start Date*: 2016-08-08 |
Sponsor Name:University Medical Center Groningen | ||
Full Title: Early identification of patients who benefit from palbociclib in addition to letrozole | ||
Medical condition: estrogen receptor positive metastatic breast cancer patients eligible for palbociclib plus letrozole treatment | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Female | |
Trial protocol: NL (Completed) | ||
Trial results: View results |
EudraCT Number: 2019-003828-21 | Sponsor Protocol Number: 71617 | Start Date*: 2020-02-10 |
Sponsor Name:St Antonius Hospital | ||
Full Title: Identification of sentinel lymph nodes in breast cancer patients through non-invasively and percutaneously fluorescent imaging using indocyanine green | ||
Medical condition: Axillar staging in breast cancer patients | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Female | |
Trial protocol: NL (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2017-001570-42 | Sponsor Protocol Number: AirGOs-2 | Start Date*: 2018-05-07 |
Sponsor Name:Helsinki University Hospital | ||
Full Title: Aggravated airway inflammation: research on genomics and optimal treatments (AirGOs) | ||
Medical condition: Acetylsalicylic acid (ASA-) exacerbated respiratory disease (AERD). | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: FI (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2021-001921-31 | Sponsor Protocol Number: GRACE | Start Date*: 2021-10-25 |
Sponsor Name:University Hospital Ghent | ||
Full Title: GRACE-trial: A randomized active-controlled trial for vulvovaginal atrophy in breast cancer patients on endocrine therapy | ||
Medical condition: Breast cancer patients on endocrine therapy (AI or SERM) with symptoms of vulvovaginal atrophy | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Female | |
Trial protocol: BE (Trial now transitioned) | ||
Trial results: View results |
EudraCT Number: 2016-002978-13 | Sponsor Protocol Number: Verde_Nano | Start Date*: 2016-09-13 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERO-UNIVERSITARIA PISANA | |||||||||||||
Full Title: Assessment of the feasibility and clinical efficacy of the ICG - 99mTc - nanocolloid for sentinel lymph node biopsy | |||||||||||||
Medical condition: Patients with breast cancer or melanoma candidates for sentinel node biopsy surgery. The regional lymph nodes are the most common site of metastatic involvement in patients with cutaneous melanoma ... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-004374-25 | Sponsor Protocol Number: 61528 | Start Date*: 2020-03-25 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERO-UNIVERSITARIA UDINE | |||||||||||||
Full Title: Thoracic duct identification with Indocyanine green fluorescence during minimally invasive esophagectomy with patient in prone position | |||||||||||||
Medical condition: Chylothorax is a serioso post-operative complication, which occurs in 2-12% of patients undergoing esophagectomy. Thoracic duct lesion leads to a reduction of body fluids and albumin resulting in h... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-003974-33 | Sponsor Protocol Number: CE150171 | Start Date*: 2021-05-25 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERO-UNIVERSITARIA UDINE | |||||||||||||
Full Title: Thoracic duct identification with indocyanine green fluorescence during esophagectomy | |||||||||||||
Medical condition: Chylothorax is a serious post-operative complication, with occurs in 2-12% of patients undergoing esophagectomy. Thoracic duct lesion leads to a reduction of body fluids and albumin resulting in hy... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-005702-22 | Sponsor Protocol Number: IELSG39 | Start Date*: 2013-03-17 |
Sponsor Name:INTERNATIONAL EXTRANODAL LYMPHOMA STUDY GROUP | ||
Full Title: International prospective Phase 2 trial addressing the efficacy of first-line Chlamydophila psittaci-eradicating therapy with protracted administration of doxycycline followed by eradication moni... | ||
Medical condition: Patients with newly diagnosed Ocular Adnexal Marginal Zone Lymphoma (OAMZL) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: IT (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2018-000590-75 | Sponsor Protocol Number: betami_vs_1.0 | Start Date*: 2018-05-31 |
Sponsor Name:Oslo University Hospital | ||
Full Title: BEta-Blocker Treatment after Acute Myocardial Infarction in revascularized patients with preserved left ventricular systolic function (BETAMI trial) | ||
Medical condition: Patients admitted to hospital with acute myocardial infarction treated With reperfusion therapy (i.e trombolysis or percutaneous coronary intervention) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NO (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2008-007474-38 | Sponsor Protocol Number: GreenLight | Start Date*: 2009-03-17 |
Sponsor Name:Leiden University Medical Center | ||
Full Title: GREEN LIGHT: Intra-operative fluorescent imaging of sentinel lymph nodes in breast cancer | ||
Medical condition: Breast cancer | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2019-003119-77 | Sponsor Protocol Number: NL67828.058.18 | Start Date*: 2020-02-24 |
Sponsor Name:Leiden University Medical Center | ||
Full Title: Near-infrared fluorescence imaging with IndoCyanine Green for the intraoperative identification of Gastrointestinal stromal cell tumours: a pilot study | ||
Medical condition: GIST Gastrointestinal stromal cell tumour | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2017-000457-39 | Sponsor Protocol Number: VX16-770-127 | Start Date*: 2019-05-03 |
Sponsor Name:Vertex Pharmaceuticals Incorporated | ||
Full Title: A Randomized, Double-blind, Placebo controlled, Crossover Study to Evaluate the Efficacy of Ivacaftor in Subjects with Cystic Fibrosis Who are 6 Years of Age and Older and Have Either a 3849 + 10KB... | ||
Medical condition: Cystic Fibrosis | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |
Trial protocol: Outside EU/EEA | ||
Trial results: View results |
EudraCT Number: 2011-006151-10 | Sponsor Protocol Number: FAME1.0 | Start Date*: 2012-02-15 |
Sponsor Name:Sønderjylland Hospital, department of neurology | ||
Full Title: FAME - Fampyra outcome measures study: a study of responsiveness of different outcome measures to Fampyra treatment. | ||
Medical condition: Multiple Sclerosis | ||
Disease: | ||
Population Age: | Gender: Male, Female | |
Trial protocol: DK (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2009-015077-12 | Sponsor Protocol Number: rrk3681 | Start Date*: 2009-11-23 |
Sponsor Name:University Hospital Birmingham NHS Foundation Trust | ||
Full Title: The use of corticosteroids (Budenofalk) as a chemopreventative agent in ulcerative colitis associated neoplasia | ||
Medical condition: chronic ulcerative colitis | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2020-001794-77 | Sponsor Protocol Number: SilCOVID19 | Start Date*: 2020-06-10 |
Sponsor Name:INSTITUT CATALÀ D'ONCOLOGIA GIRONA - HOSPITAL JOSEP TRUETA | ||
Full Title: Phase II Clinical Trial to evaluate the efficacy of silibinin supplementation in the prevention of the progression of the respiratory failure in patients with onco-hematological diseases and infect... | ||
Medical condition: COVID19 respiratory failure | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
• EEA CTAs: Date study was authorised to proceed
• Outside EU/EEA: Date study was submitted in EudraCT
• Outside EU/EEA: Date study was submitted in EudraCT
